Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
2019 · Genome biology · 118 citations
https://doi.org/10.1186/s13059-019-1867-0
O
Orsolya Rusz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
548
Citations
11
h-index
12
i10-index
Orsolya Rusz is an academic researcher from Semmelweis University. The author has contributed to research in topics: DNA Repair Mechanisms & PARP inhibition in cancer therapy & Genetic factors in colorectal cancer. The author has an h-index of 11, co-authored 64 publications.
ORCID: 0000-0001-5726-4072Papers by this author
worksOne-Year Neoadjuvant Endocrine Therapy in Breast Cancer
2015 · Pathology & Oncology Research · 19 citations
https://doi.org/10.1007/s12253-015-9911-1
Differential immunostaining of various types of breast carcinomas for growth hormone‐releasing hormone receptor – Apocrine epithelium and carcinomas emerging as uniformly positive
2014 · Apmis · 11 citations
https://doi.org/10.1111/apm.12224
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting
2024 · npj Precision Oncology · 8 citations
https://doi.org/10.1038/s41698-024-00561-6
Metadata record for the article: A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
2021 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.14452854
Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8668412
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat